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Liprin-α1 is a regulator of vimentin 
intermediate filament network in 
the cancer cell adhesion machinery
Henna Pehkonen1, Pernilla von Nandelstadh1, Piia-Riitta Karhemo1, Tatiana Lepikhova1, 
Reidar Grenman2, Kaisa Lehti1,3,4 & Outi Monni1
PPFIA1 is located at the 11q13 region, which is one of the most commonly amplified regions in several 
epithelial cancers including head and neck squamous cell carcinoma and breast carcinoma. Considering 
the location of PPFIA1 in this amplicon, we examined whether protein encoded by PPFIA1, liprin-α1, 
possesses oncogenic properties in relevant carcinoma cell lines. Our results indicate that liprin-α1 
localizes to different adhesion and cytoskeletal structures to regulate vimentin intermediate filament 
network, thereby altering the invasion and growth properties of the cancer cells. In non-invasive cells 
liprin-α1 promotes expansive growth behavior with limited invasive capacity, whereas in invasive cells 
liprin-α1 has significant impact on mesenchymal cancer cell invasion in three-dimensional collagen. 
Current results identify liprin-α1 as a novel regulator of the tumor cell intermediate filaments with 
differential oncogenic properties in actively proliferating or motile cells.
Liprin-α 1 is encoded by PPFIA1 located at the 11q13 locus, which is one of the most commonly amplified region 
in several epithelial cancers such as those arising in head and neck1,2, breast3,4, and ovarian cancer5,6. The impor-
tance of 11q13 amplification in epithelial cancers is highlighted by its association with poor prognosis3,7,8. In 
squamous cell carcinoma of head and neck, PPFIA1 shows high correlation between DNA copy number and gene 
expression1,2,7,9. Despite its location in commonly amplified region, the role of liprin-α 1 in cancer progression 
has not been studied in detail. Furthermore, the previously reported function of liprin-α 1 for epithelial cancer 
cell migration is controversial. In head and neck cancer cells, depletion of liprin-α 1 enhances migratory prop-
erties10, whereas in breast cancer cells its depletion leads to decreased migration and extracellular matrix (ECM) 
degradation11. In colon carcinoma cells, liprin-α 1 has a positive effect on cell motility, which has been linked to 
interaction with the tumor suppressor protein ING412.
Liprin-α 1 belongs to the liprin (LAR[leukocyte common antigen related]-interacting protein) family, which 
consists of liprin α - and β - cytosolic adaptor and scaffold proteins13. Liprin-α proteins have been mainly studied 
in neurons, where they function in active synaptic zones and post-synaptic sites14,15 as well as have a role in synap-
tic vesicle trafficking16,17. In non-neuronal cells, liprin-α proteins have several functions related to cell adhesion, 
signal transduction and organization of the cytoskeleton18–20. Importantly, liprin-α 1 is essential for the regulation 
of invadosome function and cell spreading as well as focal adhesion dynamics11,19. Regulation of focal adhesion 
dynamics is a complex process that involves interplay of various proteins, including those at the actin cytoskel-
eton and vimentin intermediate filament networks, which are interlinked in an adhesion dependent manner21. 
Vimentin network regulates focal adhesion size and focal contacts, functioning as both the scaffold and stabilizer 
for cell-matrix adhesion22,23.
Besides focal adhesions, podosomes, which are dynamic multiprotein structures with an outer adhesion ring 
and a cytoskeletal core, contribute to cell adhesion. Podosomes are found widely in motile cells such as mac-
rophages, endothelial cells, transformed fibroblasts, osteoclasts, malignant B lymphocytes and carcinoma cells24–30. 
Podosomes can degrade ECM, they stabilize cellular elements, and are linked to directional movement31–33. In 
cancer cells podosome-like adhesion structures with adhesion rings, are proposed to be required for maturation 
of invadopodia34. In addition, podosome-like structures have been proposed as precursors for invadopodia, the 
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ECM degrading structures that promote invasion of the transformed cells31,35–37. Due to many similar character-
istics, the terms podosomes and invadopodia are sometimes used interchangeably. To avoid misunderstanding, 
a term invadosome was recently introduced to describe all the adhesive structures that are involved in ECM 
degradation and invasion38.
The aim of our study was to investigate the potential role of liprin-α 1 in cellular signaling related to the 
adhesion, migration and invasion of cells from squamous cell carcinoma of head and neck and breast cancer. We 
discovered that liprin-α 1 localizes to the distinct cell adhesion structures, and regulates the intermediate filament 
vimentin network, thereby exerting effects on cell invasive growth.
Results
Liprin-α1 regulates tumor cell invasive growth in 3D collagen. Contradictory results have been 
reported regarding the effects of liprin-α 1 on the motility of head and neck squamous cell carcinoma (HNSCC) 
and breast cancer cell lines (Table 1)10,11, although both these cell types display frequent 11q13 amplification. 
Therefore, to examine the potential functions of liprin-α 1 in migration and invasive growth of HNSCC and 
breast carcinoma cells, UT-SCC-95, SCC-25 and MDA-MB-231 cells were subjected to transwell migration assays 
through Matrigel (Supplementary Figure 1A). Because HNSCC cells barely migrated through this matrix we 
embedded the cells as single-cell suspension in three-dimensional (3D) collagen that typifies the tumor adjacent 
ECM. During a 5-day culture, the control SCC-25 and UT-SCC-95 cells (shScr) displayed an expansive growth 
behavior with limited invasive activity into the cell-surrounding collagen. In SCC-25 cells, the knockdown of 
endogenous liprin-α 1 by lentiviral shRNA diminished the cell-cell adhesive growth pattern and turned the cells 
to a more invasive phenotype with less prominent cell-cell contacts in 3D collagen. Liprin-α 1 knockdown did not 
significantly affect UT-SCC-95 cell invasion, although less regular colonies and actin assembly to cell edges and 
protrusions was observed also in these cells (Fig. 1A). In the highly invasive MDA-MB-231 and Hs578T breast 
cancer cells that display different types of multi-cellular outgrowths and singly invading cells with mesenchymal 
morphology, liprin-α 1 knockdown instead reduced the colony size and invasion (Fig. 1A). Efficiency of liprin-α 1 
knockdown was verified by western blot (Fig. 1B), and liprin-α 1 protein levels were confirmed to correlate with 
status of PPFIA1 amplification in HNSCC cell lines (Fig. 1C). Our data suggest that, liprin-α 1 is needed for the 
expansive growth behavior and prominent intercellular contacts of the primary HNSCC cells within 3D collagen, 
whereas in MDA-MB-231 and Hs578T cells liprin-α 1 promotes mesenchymal cell invasion, concurring with the 
previous results of opposite liprin-α 1 effects reported in HNSCC and breast cancer cell invasion.
Liprin-α1 localizes to adhesion rings in HNSCC from primary tumor. In order to examine the poten-
tial direct liprin-α 1 functions in cell-cell adhesion, we followed spheroid formation of the control (shScr) and 
liprin-α 1 knockdown (shPPFIA1) HNSCC cells in low-adherent plates in the absence of the 3D matrix. However, 
the spheroid formation and cell-cell contacts displayed by the control UT-SCC-95 and SCC-25 cells remained 
unaltered after liprin-α 1 knockdown (Supplementary Figure 1B). This raised the possibility that, instead of direct 
regulation of intercellular junctions, liprin-α 1 alters cell-cell contacts and invasion via collagen and β 1-integrin 
mediated signals. To study whether liprin-α 1 is involved in β 1-integrin signalling and adhesion or cytoskeletal 
structures, the localization of liprin-α 1, other focal adhesion proteins, and the 11q13 encoded protein cortactin 
were analyzed by immunofluorescence in HNSCC cell lines from primary tumor from tongue. In the UT-SCC-95 
cells, liprin-α 1 was prominently localized to the adhesion rings, where it co-localized with activated β 1-integrin 
(Fig. 2A), whereas vinculin was located closer to the cortactin- and actin-rich cores of the adhesive structures 
(Fig. 2A; Supplementary Figure 2A). Instead, in the SCC-25 HNSCC cell line, liprin-α 1 localized primarily near 
or at the focal adhesions and less prominently to adhesion rings (Fig. 2A, Supplementary Figure 2B). In general, 
liprin-α 1 displayed a more distant localization at the outer edges of the adhesion rings compared to pFAK, pax-
illin and talin (Supplementary Figure 2A,B). Interestingly, endogenous liprin-α 1 and talin both localized in the 
same adhesive structures (Fig. 2A, Supplementary Figure 2B) and liprin-α 1 co-immunoprecipitated with talin in 
SCC-25 and UT-SCC-95 cell lines (Supplementary Figure 2B).
Since liprin-α 1 had contribution to invasive cell growth of breast cancer cells into collagen I (Fig. 1), we com-
pared localization of liprin-α 1 in HNSCC and in invasive breast cancer cell lines. In Hs578T and MDA-MB-231 
breast cancer cells, liprin-α 1 was detected near or at the lamellipodia (Fig. 2B, Supplementary Figure 3A) 
Cell line Description of the cell line Location P/M 11q13+
MDA-MB-231 breast adenocarcinoma breast M no
Hs578T breast carcinoma breast P no
SCC-25 head and neck squamous cell carcinoma tongue P yes
UT-SCC-19A head and neck squamous cell carcinoma larynx P no
UT-SCC-19B head and neck squamous cell carcinoma larynx P (per) yes
UT-SCC-24A head and neck squamous cell carcinoma tongue P yes
UT-SCC-24B head and neck squamous cell carcinoma neck M (per) yes
UT-SCC-42A head and neck squamous cell carcinoma tongue P no
UT-SCC-42B head and neck squamous cell carcinoma neck M no
UT-SCC-95 head and neck squamous cell carcinoma tongue P no
Table 1.  Characteristics of the cell lines used in the study. Abbreviations: P = primary tumor, M = metastasis, 
per = persistent disease, 11q13+ = cases with 11q13 gain or amplification.
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suggesting that this localization is typical for migrating cells that lack strong adhesion rings. In our study, 
liprin-α 1 and cortactin were not found in the same structures of the breast cancer cell lines because these cells did 
not form adhesion rings as compared to HNSCC cells originating from primary tumor (Fig. 2). Knockdown of 
liprin-α 1 changed the focal adhesion morphology to smaller adhesions at the periphery of Hs578T breast cancer 
cells (Fig. 2B).
Liprin-α1 is involved in extracellular matrix degradation in HNSCC and localizes to different 
adhesion related structures depending on cell origin. To determine the potential function of 
liprin-α 1 related to invadosome activity, we first analyzed the ability of primary HNSCC cells to degrade ECM. 
The gelatin degradation assay revealed that liprin-α 1 containing adhesion rings in the UT-SCC-95 and SCC-25 
cell lines were able to degrade ECM (Fig. 3A). To analyze, if liprin-α 1 regulates adhesion ring mediated matrix 
degradation, we used lentiviral shRNA to knockdown liprin-α 1 in the UT-SCC-95 cell line. However, cortactin, 
vinculin and actin were recruited to the adhesion rings after liprin-α 1 knockdown, indicating that liprin-α 1 
Figure 1. Liprin-α1 regulates cell invasive growth in collagen. (A) HNSCC and breast carcinoma cells were 
embedded in 3D collagen after liprin-α 1 silencing and cultured for 5 days. Confocal micrographs show F-actin 
(phalloidin, red) and nuclei (DAPI, blue) in representative colonies. Quantification of the invasive growth is 
expressed as relative area of colonies or relative area/nuclei; mean ± SEM; three collagen preparations/stable 
control (shScr) or knockdown (shPPFIA1) cell line. *P < 0.05, unpaired Student’s t-test. (B) Western blots 
verifying liprin-α 1 knockdown in SCC-25, UT-SCC-95, MDA-MB-231 and Hs578T cell lines. (C) HNSCC cells 
with PPFIA1 amplification show higher expression of liprin-α 1.
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was not essential for adhesion ring formation (Fig. 3B). Liprin-α 1 knockdown neither prevented the matrix 
degrading capability of the UT-SCC-95 cells (Fig. 3B, Supplementary Figure 3B). Our results suggest, that in con-
trast to the previously reported functions in the dynamics of ECM degradation and invadosomes in the invasive 
Figure 2. Localization of liprin-α1 and other adhesion proteins in HNSCC cell lines from primary tumor 
and effect of liprin-α1 knockdown on cortactin and vinculin expression in invasive breast cancer cells. 
(A) Co-localization of liprin-α 1 with activated β 1 integrins in adhesion rings and localization of vinculin and 
cortactin into the inner part and core of adhesion rings, respectively, in UT-SCC-95 HNSCC cells. Localization 
of talin and liprin-α 1 in adhesion structures in SCC-25 HNSCC cell line. The last figure in each panel shows 
the enlargement of the overlay image, as indicated by the scale bar. (B) Knockdown of liprin-α 1 did not inhibit 
localization of cortactin in invadopodia as compared to the control cells transduced with scrambled shRNA 
in Hs578T breast cancer cells. Vinculin staining reveals differences in the shape and size of focal adhesions 
in Hs578T breast cancer cells after liprin-α 1 knockdown as compared to control cells. The scale bar is 10 μm. 
*P < 0.05, unpaired Student’s t-test.
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MDA-MB-231 cells11, depletion of liprin-α 1 does not affect the capability of poorly collagen-invasive cells to 
degrade extracellular matrix. Strong adhesion ring formation in non-invasive cells can explain the differences 
between cell lines.
Due to the fact that liprin-α 1 knockdown affected invasive cell growth differently in primary HNSCC and 
metastatic breast cancer cells, we compared the localization of liprin-α 1 in primary and primary persistent or 
metastatic cell lines from the same HNSCC patient. Similar to other HNSCC cell lines from primary tumor, 
liprin-α 1 was found either around the cortactin-containing core outside of vinculin or at the lamellipodia at the 
vicinity of vinculin positive small focal adhesions (Fig. 3C). Adhesion ring formation was not specific for one 
cell line, but occurred in several head and neck cancer cell lines derived from primary tumors (Figs 2A and 3C). 
Figure 3. Liprin-α 1 localizes to extracellular matrix degrading complexes and liprin-α 1 localization 
differs based on the origin of the cell line. (A) Localization of liprin-α 1 at the extracellular degrading 
complexes in HNSCC. Degrading areas are shown in black and fluorescent gelatin in green. (B) Knockdown of 
liprin-α 1 did not prevent adhesion ring formation or ECM degradation in non-invasive HNSCC. (C) Liprin-α 1 
localization differs between the cell lines obtained from primary tumor and metastasis from the same patient. 
Liprin-α 1 localized to invadosome adhesion rings with cortactin and vinculin in HNSCC cell line from primary 
tumor (UT-SCC-24 A and UT-SCC-42 A), whereas in metastatic cell lines (UT-SCC-24B and UT-SCC42B) 
liprin-α 1 was located near cell edge and cortactin localized to invadopodia. The scale bar is 10 μm.
www.nature.com/scientificreports/
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Instead liprin-α 1 was mostly located near or at the lamellipodia together with vinculin in corresponding meta-
static cell lines (Fig. 3C). This finding is in line with the localization of liprin- α 1 in metastatic breast cancer cells 
(Fig. 2B). Our experiments also showed that in metastatic cells with large and spread lamellipodia, liprin-α 1 
was detected in a front near lamellipodia, as well as at the leading edge partially localizing with vinculin-positive 
focal adhesions (Supplementary Figure 3C). As observed in breast cancer cells (Fig. 2B), knockdown of liprin-α 1 
did not prevent formation of focal adhesions or cortactin-positive structures in metastatic or primary persistent 
HNSCC cell lines, although focal adhesions were smaller or more elongated than in control cells (Supplementary 
Figure 4A,B).
Due to differences in the role of liprin-α 1 in promoting invasion in primary and invasive cancer cells, we 
examined the invasion capabilities of primary and metastatic HNSCC cell lines obtained from the same patient. 
Our results showed that metastatic or primary persistent HNSCC cancer cells (UT-SCC-19B, − 24B and − 42B) 
displayed higher invasive capacity than corresponding cells from primary tumor (UT-SCC-19A,− 24A and 
− 42A) (Fig. 4) explaining differences in localization of liprin-α 1 and cortactin in different types of cell lines. In 
metastatic HNSCC cell lines liprin-α 1 showed same localization pattern as compared to invasive breast cancer 
cells (Figs 2 and 3).
Liprin-α1 regulates intermediate filament vimentin. To study the more precise mechanism of 
liprin-α 1 function, we assessed the effect of liprin-α 1 knockdown or overexpression to gene expression by 
microarray analysis. Interestingly, liprin-α 1 knockdown altered the gene expression levels of VIM (Table 2). We 
also found, that PPFIA1 alters expression of MMP13 (Table 2) located at the 11q22 region which is reported to 
be related to cell invasion, growth and aggressiveness of HNSCC39–41. Moreover, while the intermediate filament 
keratins KRT1, KRT4, KRT10 and KRT13 were downregulated, VIM was upregulated in PPFIA1 shRNA treated 
cells (Table 2). In addition, liprin-α 1 overexpression in UT-SCC-95 cells reduced the VIM expression and upreg-
ulated MMP13 (Table 3).
In the UT-SCC-95 cell line vimentin intermediate filaments were localizing with liprin-α 1 around adhe-
sion ring (Fig. 5A). Vimentin upregulation after knockdown of liprin-α 1 was observed in several HNSCC cell 
lines. Upregulation was detected in metastatic UT-SCC-24B and UT-SCC-42B cell lines (Fig. 5B) as well as in 
primary UT-SCC-95 and SCC-25 HNSCC cells (Fig. 5C,D). Vimentin expression was significantly lower in 
control HNSCC cells as compared to breast cancer cells, which express high levels of vimentin (Fig. 5C). In 
the UT-SCC-95 cell line, overexpression of liprin-α 1 led to vimentin downregulation, further supporting our 
results on a regulative role of liprin-α 1 in vimentin expression (Fig. 5E). Increased vimentin expression was only 
Figure 4. Invasive growth of primary (A) and metastatic or primary persistent cell lines (B) from the same 
patient. (A) HNSCC carcinoma cells were embedded in 3D collagen as a single cell suspension. Representative 
confocal micrographs show F-actin (phalloidin) and nuclei (DAPI) in cell colonies after 8 days in culture.  
(B) Quantification of the invasive growth is expressed as relative percentage of invading colonies; the A cell line 
was set as 1. The error bars indicate mean ± SEM. Five collagen preparations/cell line. *P < 0.01, **P < 0.001, 
unpaired Student’s t-test. (C) Light micrographs of collagen cross sections visualize H&E-stained cells after 9 
days in culture.
www.nature.com/scientificreports/
7Scientific RepoRts | 6:24486 | DOI: 10.1038/srep24486
detected in the insoluble or cytoskeletal fraction of knockdown cells (Fig. 5F,G). Both vimentin and liprin-α 1 has 
been shown to regulate β 1-integrin trafficking42,43. Therefore, we wanted to test whether liprin-α 1 knockdown 
has any effect on β 1-integrin levels in HNSCC cells. β 1-integrin was accumulating in the soluble fraction of the 
cells upon liprin-α 1 knockdown, but no effect was found on the early (EEA1) or recycling (Rab11) endosome 
proteins (Fig. 5F). On the other hand PKCε , which is necessary for integrin recycling, was slightly upregulated 
together with β 1 integrins in the soluble fraction of knockdown cells (Fig. 5F). Our data supports previous find-
ings showing that liprin-α 1 participates in β 1-integrin signalling, required for effective migration, particularly 
in motile cells.
Vimentin was highly expressed at the cell colony edge in UT-SCC-24B cells, whereas MDA-MB-231 showed 
a strong vimentin network throughout the cells (Fig. 6A,B). Liprin-α 1 knockdown led to vimentin accumulation 
near the nucleus in both of these cells (Fig. 6A,B) as well as formation of vimentin bridges and multinucleated 
cells in both the HNSCC and breast cancer cell lines (Fig. 6). Furthermore, invaginated nuclei were found in 
breast cancer cells (Fig. 6D,G). Our data suggests that liprin-α 1 stabilizes the cell membrane and cytoskeletal 
elements in motile cells. Although knockdown of liprin-α 1 caused an effect on vimentin expression in several 
cell lines, it did not alter significantly the levels of other proteins related to epithelial to mesenchymal transition 
or other focal adhesion proteins nor cortactin (Supplementary Figure 5A–C). Similarly, knockdown of cortactin 
did not significantly affect the levels of any of the studied focal adhesion proteins or liprin-α 1 (Supplementary 
Figure 5C). As an important conclusion, our data shows for the first time that liprin-α 1 regulates the vimentin 
intermediate filament network influencing cell division and morphology.
Liprin-α1 knockdown affects cell growth in several cancer cell lines. Cytoskeletal reorganization as 
well as changes in focal adhesion dynamics are related to cell transformation during cancer progression44. Because 
liprin-α 1 knockdown led to formation of vimentin accumulation and vimentin bridges (Fig. 6), we next assessed 
the effect of liprin-α 1 to anchorage independent cell growth in soft agar. HNSCC cell lines showed only limited 
growth in soft agar (data not shown), whereas the invasive breast cancer cells, which had undergone epithelial to 
mesenchymal transition showed colony forming capability (Fig. 7A). Breast cancer cells were used to assess the 
effect of liprin-α 1 on cell growth in highly motile and invasive cells, with less cell-cell contacts. Liprin-α 1 knock-
down reduced the size of colonies in soft agar (Fig. 7A). MTT-assay for cell growth showed reduced metabolic 
activity in liprin-α1 knockdown cells compared to control cells when breast cancer and HNSCC cell lines were 
grown in 2D culture (Fig. 7B). However, when liprin-α 1 was knocked down in the UT-SCC-95 cell line, which 
does not have 11q13 amplification and has lower expression level of liprin-α 1 than those with amplification, 
there was no effect on cell growth. This implies that the function of liprin-α 1 in promoting oncogenic properties 
is emphasized in more motile and actively proliferating cells.
Discussion
Liprin-α 1 is a member of the LAR protein-tyrosine phosphatase-interacting protein family with a role in cell 
edge dynamics and cell motility18,19,43. Liprin-α 1 is encoded by PPFIA1, which is located at the 11q13 region. 
Gene Description FC log 2 p-value
VIM vimentin 2,5 0,00105
KRT4 keratin 4 − 1,9 0,000787
KRT10 keratin 10 − 2,47 0,000361
MMP13 matrix metallopeptidase 13 (collagenase 3) − 2,3 0,000361
PPFIA1
protein tyrosine phosphatase, receptor 
type, f polypeptide (PTPRF), interacting 
protein (liprin), alpha 1
− 0,98 0,01315
KRT13 keratin 13 − 1,59 0,007413
KRT1 keratin 1 − 1,29 0,012416
Table 2.  Differential expression of genes related to intermediate filaments and extracellular matrix in 
UT-SCC-24B cells with PPFIA1 knockdown. Cells with liprin-α 1 knockdown were compared to control cells 
containing non-target shRNA. Fold change (FC) is in log 2 scale and it has been calculated from three replicates.
Gene Description
FC log 2 
replicate1




PPFIA1 protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 1,89 2,42 2,16
VIM vimentin − 2,04 − 2,07 − 2,05
MMP13 matrix metallopeptidase 13 (collagenase 3) 1,18 1,06 1,12
Table 3.  Differential expression of genes related to intermediate filaments and extracellular matrix in 
UT-SCC-95 cells with ectopic expression of PPFIA1. Cells with liprin-α 1 expression were compared to 
corresponding control cells containing empty vector. Fold change (FC) is in log 2 scale and the values are shown 
separately from two replicates.
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PPFIA1 maps next to CTTN, which encodes for cortactin, and they are co-amplified in 20–30% of HNSCC1,2 and 
10–20% of breast cancer cells45. Despite the location of PPFIA1 in one of the most commonly amplified regions 
in many epithelial cancers, the role of liprin-α 1 in cancer progression has not been studied precisely. Previous 
studies show contradictory role of liprin-α 1 in cancer cell invasion. Liprin-α 1 depletion increases invasion of 
head and neck squamous cell carcinoma cells10, whereas the effect is opposite on breast cancer11. Our aim herein 
was to study the function of liprin-α 1 and evaluate whether PPFIA1/liprin-α 1 possesses oncogenic properties in 
cancers where it is often amplified. Our results support the recent findings in breast cancer, because knockdown 
of liprin-α 1 reduced the colony size and cell invasive growth in 3D collagen for highly invasive breast cancer cells. 
On the other hand, in HNSCC UT-SCC-95 cells originating from primary tumor with no PPFIA1 amplification, 
knockdown of liprin-α 1 did not have effect on the invasive cell growth. UT-SCC-95 cells have tight cell-cell 
Figure 5. Knockdown of liprin-α1 affects vimentin expression in HNSCC cells. (A) Localization of vimentin 
intermediate filaments around and close to adhesion rings in UT-SCC-95 HNSCC cell line. The last figure in the 
panel shows the enlargement of the overlay, as indicated by the scale bar. Scale bar is 10 μm. (B) Effect of liprin-α 1 
knockdown on vimentin expression in metastatic and primary persistent HNSCC cell lines (C,D) Effect of 
liprin-α 1 knockdown on vimentin expression in UT-SCC-95 and SCC-25 HNSCC cell lines and highly invasive 
breast cancer cell lines MDA-MB-231 and Hs578T. (E) Vimentin expression was decreased upon liprin-α 1 
overexpression in UT-SCC-95 cell line. (F) Knockdown of liprin-α 1 led to accumulation of total β -integrin in 
metastatic cell lines and slight increase in PKCε expression. Knockdown of liprin-α 1 did not affect the expression 
of EEA1 (early endosomes) or Rab11 (recycling endosomes) in soluble fraction of HNSCC cells. (G) Liprin-α 1 
knockdown caused vimentin accumulation in insoluble fraction of HNSCC cell lines.
www.nature.com/scientificreports/
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contacts and adhesion rings, which might explain the lack of effect on cell growth. However, singly embedded 
liprin-α 1 knockdown SCC-25 cells with PPFIA1 amplification changed the cohesive growth pattern to more 
efficient invasive growth with less cell-cell contacts and irregular colony morphology in 3D collagen. Liprin-α 1 
has previously reported functions in cell spreading by stabilization of lamellipodial protrusions, regulation of 
invadosome dynamics, degradation of extracellular matrix in invasive breast cancer cells, and in vivo metastatic 
Figure 6. Liprin-α1 knockdown causes changes in vimentin intermediate filament network in HNSCC and 
breast carcinoma cells. (A,B) Liprin-α 1 and vimentin staining in control cells and vimentin structures near 
nucleus or vimentin bridge in metastatic HNSCC and breast cancer cells with knockdown of liprin-α 1. The 
scale bar is 10 μm. (C,D) Formation of vimentin bridge structures as well as multinucleated and irregular nuclei 
in metastatic HNSCC and breast cancer cells with knockdown of liprin-α 1. (E) Quantification of vimentin 
positive cells in UT-SCC-24B cells with shScr and shPPFIA1 liprin-α 1 knockdown. (F) Quantification of 
vimentin aggregates located near nucleus in shScr and shPPFIA1 liprin-α 1 knockdown UT-SCC-24B cells. (G) 
Quantification of invaginated nuclei in shScr and shPPFIA1 knockdown cells in the MDA-MB-231 cell line. 
Error bars indicate standard deviations (s.d.) from three independent experiments. P < 0.05, unpaired Student’s 
t-test. Arrow head indicates invaginated nucleus. Arrows indicate vimentin bridges. The scale bar is 20 μm.
www.nature.com/scientificreports/
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cell invasion11,19,46,47. Our results support previous findings on the function of liprin-α 1 in cell invasive growth 
and demonstrate morphological changes such as cellular junctions and front-rear cell polarity as well as changes 
in focal adhesion morphology in invasive cells. Furthermore, in highly invasive breast cancer cells as well as 
HNSCC cells originating from metastasis or primary persistent as well as primary tumor with PPFIA1 amplifi-
cation, liprin-α 1 expression correlated with growth properties of the cells. Taken together, these results illustrate 
that liprin-α 1 encompasses oncogenic properties in several actively proliferating and motile HNSCC and breast 
cancer cells.
To find explanations for differences in liprin-α 1 function in different cancer cells, we studied comprehen-
sively the localization of liprin-α 1 in different HNSCC and breast cancer cell lines. We found for the first time 
that in head and neck cancer from primary tumor, liprin-α 1 was localized to invadosome containing adhesion 
ring structures. Interestingly, PPFIA1 and CTTN are located next to each other at the 11q13 amplicon and both 
the liprin-α 1 and cortactin were localized in the same adhesive structures. In contrast, in metastatic or pri-
mary persistent HNSCC cell lines as well as in motile and invasive breast cancers, liprin-α 1 localized close to 
focal adhesions near the protruding cell edge, suggesting a function of liprin-α 1 in cell migration. In invasive 
MDA-MB-231 cell line, liprin-α 1 knockdown has been shown to affect ECM degradation and cell invasion11. 
We showed that in primary HNSCC cells, liprin-α 1 knockdown did not prevent adhesion ring dependent ECM 
degradation. This was expected since liprin-α 1 knockdown did not promote cell invasive growth in non-invasive 
HNSCC cells. Liprin-α 1 depletion resulted in deformation of focal adhesions at the cell periphery in metastatic 
HNSCC and breast cancer cells, suggesting a role of liprin-α 1 in adhesion turnover in these cells. Taken together, 
our results clearly showed that liprin-α 1 localizes to different adhesion related structures depending on the char-
acteristics of the cell line, explaining differences of the function of liprin-α 1 in cell adhesion, growth and cell 
invasion in different tumor cells.
To study the mechanism of liprin-α 1 in cell growth and invasion, we carried out gene expression analy-
sis from liprin-α 1 knockdown and overexpressing cells. We showed that liprin-α 1 knockdown led to vimentin 
up-regulation in HNSCC cells at gene expression level. Liprin-α 1 overexpression, on the other hand, caused the 
Figure 7. Effect of liprin-α1 knockdown on cell growth. (A) Liprin-α 1 knockdown reduces the size of 
colonies in Hs578T breast cancer cells grown in soft agar. Error bar was calculated from three independent 
experiments and indicate standard deviations (s.d.). *P < 0.05, unpaired Student’s t-test. (B) MTT- proliferation/
cell viability assays for different HNSCC and breast cancer cell lines. Each experiment was done in triplicate. 
The difference in cell growth between PPFIA1 shRNA cells and Scr shRNA cells was statistically significant at 
the last day of the experiment (P < 0.05, unpaired Student’s t-test, error bars indicate s.d. calculated from three 
independent experiments) in all cell lines except for UT-SCC-95.
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opposite effect on vimentin expression further strengthening the regulative role of liprin-α 1 in intermediate fil-
ament regulation. In our experiments vimentin upregulation was detected in the insoluble fraction of cells from 
primary tumor as well as in metastatic cell line lacking adhesion rings, which suggests that vimentin recycling 
or function was disrupted. Our results demonstrated that in liprin-α 1 knockdown cells from metastatic HNSCC 
MMP13 and keratins KRT1, KRT4, KRT10 and KRT13 were significantly underexpressed when vimentin was 
upregulated. Liprin-α 1 knockdown resulted in vimentin overexpression and accumulation in cells which do not 
express large amounts of vimentin endogenously. Based on our data, we hypothesize that effect of liprin-α 1 on 
adhesion is related to intermediate filament regulation and cells compensate the absence of liprin-α 1 and under-
expression of keratin intermediate filaments by overexpressing vimentin in HNSCC.
We studied the location of vimentin in HNSCC and breast cancer cells. Vimentin was widely expressed in 
breast cancer, whereas in metastatic HNSCC it was expressed only in minority of the cells and mostly in cells at 
the colony edge. In UT-SCC-95 primary HNSCC cells, vimentin was located around adhesion rings, suggesting a 
function of liprin-α 1 and vimentin intermediate filaments in adhesion ring regulation. In MDA-MB-231 breast 
cancer cells with liprin-α 1 knockdown, vimentin cage structure was detected near the nucleus and in metastatic 
UT-SCC-24B HNSCC cells, vimentin accumulated as aggregates near the nucleus. Furthermore, nuclei were 
abnormal in shape, or multinucleated and vimentin bridges were formed in these cell lines, demonstrating distur-
bances in cell division. Previously, dysfunction in vimentin regulation has been demonstrated to lead to vimentin 
bridges48,49. Because liprin-α 1 silencing and overexpression clearly resulted in changes in vimentin gene and pro-
tein expression levels and liprin-α 1 knockdown did not affect other epithelial-to-mesenchymal transition related 
proteins, we suggest that the effects of liprin-α 1 silencing on cellular morphology and growth are partly due to the 
vimentin dysregulation. Overall, our findings show that liprin-α 1 is an important regulator of the intermediate 
filament network in epithelial cancer cells.
Previous studies have revealed several fundamental functions for vimentin in cell adhesion, migration and 
cellular signaling as well as in cell proliferation and contractibility44,50–53. Vimentin regulates β 1-integrin recy-
cling42 and recently, liprin-α 1 was found to be involved in the internalization of integrins in MDA-MB-231 breast 
cancer cells43. To test whether liprin-α 1 had any effect on β 1-integrin protein levels, we knocked down liprin-α 1 
in several HNSCC cell lines and discovered that total β 1-integrin was accumulating in the soluble fraction of 
the metastatic cells whereas no effect was found on early or recycling endosomes. Vimentin accumulated only 
in insoluble fraction of the cells. In non-motile cells, liprin-α 1 co-localized with activated β 1 integrins and talin 
in invadosomes containing adhesion rings and it co-immunoprecipitated with talin. Altogether, our results 
are in line with previous data from invasive breast cancer cells and provide additional evidence on the role of 
liprin-α 1 in β 1-integrin signaling also in HNSCC. The function of talin and liprin-α 1 in proper dynamics at 
the cell edge during cell motility and in cell spreading is concentration dependent19. Therefore, interactions and 
balance between liprin-α 1 and proteins related to invadosomes and adhesive structures are affecting the invasive 
behavior of the cells.
Taken together, our results demonstrate that liprin-α 1 is a novel regulator of vimentin thereby contributing 
to cytoskeletal organization as well as to cellular structures related to adhesion in epithelial cancers. Our data 
implies that liprin-α 1 is a potential stabilizer for adhesive structures and a fundamental player in many critical 
physiological processes in cancer cells.
Materials and Methods
Cell lines and reagents. Head and neck squamous cell carcinoma cell lines UT-SCC-19A, UT-SCC-19B, 
UT-SCC-24A, UT-SCC-24B, UT-SCC-42A, UT-SCC-42B, and UT-SCC-95 were established from clinical squa-
mous cell carcinoma samples of oral tissue by Professor Reidar Grénman (Department of Otorhinolaryngology 
– Head and Neck Surgery, Turku University Hospital, Finland). CCD-1106 cell line was established from human 
keratinocytes, SCC-25 from squamous cell carcinoma of oral tongue, MDA-MB-231 from metastatic breast ade-
nocarcinoma and Hs578T from breast carcinoma (ATCC). UT-SCC and MDA-MB-231 cell lines were cultured 
in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 2 mM L-glutamine, 0,1 mM non-essential 
amino acids (NEAA), penicillin/streptomycin (100 U/ml) from Lonza and 10% fetal bovine serum (FBS) from 
Gibco. SCC-25 cells were cultured in 1:1 mixture of Dulbecco’s modified Eagle’s medium and Ham’s F12 medium, 
containing 1.2 g/L sodium bicarbonate, 2.5 mM L-glutamine, 15 mM HEPES, penicillin/streptomycin (100 U/ml), 
0.5 mM sodium pyruvate from Lonza and 10% fetal bovine serum from Gibco. Hs578T cells were cultured in 
RPMI-1640 medium with 2 mM L-glutamine, 0,1 mM NEAA, penicillin/streptomycin (100 U/ml) from Lonza 
and 10% FBS from Gibco. CCD-1106 cell line was cultured in SFM keratinocyte medium supplemented with 
epidermal growth factor (EGF) and bovine pituitary extract (BPE) from Life Technologies as well as penicillin 
and streptomycin (100 U/ml) from Lonza.
Constructs. SH002 shScramble (shScr) control and constructs targeting PPFIA1 and CTTN were purchased 
from TRC.1 library in pLKO.1 vector (Sigma-Aldrich, St. Louis, MO, USA). Five shRNA constructs for both 
genes were tested and those giving efficient knockdown were selected for further analyses. These constructs 
were TRCN0000002969 for PPFIA1 and TRCN0000040274 and TRCN0000040275 for CTTN. Open reading 
frame (ORF) for PPFIA1 (clone ID 4794300) was ordered from the ORFeome Collection (Open Biosystems, 
Pittsburgh, PA, USA) and cloned from donor pENTR221 vector into lentiviral destination expression vector 
pLenti6/V5 DEST (Invitrogen) using Gateway cloning system. Empty pLenti6/V5 DEST vector was used as a 
control. Gateway cloning was done at the Genome Biology Unit, University of Helsinki, Finland.
Antibodies. Antibodies for talin (Sigma-Aldrich), vinculin (Sigma-Aldrich), liprin-α 1 (Proteintech), cort-
actin (clone 4F11, Millipore), phalloidin AlexaFluor-594 and AlexaFluor-488 (Life Technologies), activated 
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β 1-integrin (12G10, Abcam), total β 1-integrin (BD Transduction Laboratories), paxillin (BD Transduction 
Laboratories), pFAK (BD Transduction Laboratories), vimentin (Sigma-Aldrich), N-cadherin (Abcam), 
b-actin (Santa Cruz), MT1-MMP (Millipore), Rab11 (BD Transduction Laboratories), EEA1 (BD Transduction 
Laboratories), PKCε (BD Transduction Laboratories) and E-cadherin (BD Transduction Laboratories) were used 
in immunofluorescence and western blotting. Phalloidin-TRITC and collagen type I from rat tail (Sigma-Aldrich) 
were used in invasion assays. Secondary antibodies goat anti-mouse AlexaFluor-488 and goat anti-rabbit Alexa 
Fluor-594 (Life Technologies) were used in 1:400 dilution in immunofluorescence. For immunoblotting, second-
ary antibodies HRP-Goat Anti-Mouse IgG (H + L) and HRP-Goat Anti-Rabbit IgG (H + L) (Life Technologies) 
were used in 1:10000–20000 dilution.
Generation of cells with knockdown of PPFIA1 and CTTN by shRNA constructs and overexpression 
of PPFIA1 by ORF. Lentiviral particles containing shRNA constructs or ORF for PPFIA1 were done at the 
Biomedicum Functional Genomics Unit, University of Helsinki, Finland. Cells were seeded into 12-well plates and 
incubated overnight. Next day the cells were infected with lentiviral particles containing shRNA or ORF constructs 
with polybrene (hexadimethrine bromide (8 μg/ml), Sigma-Aldrich), and centrifuged for 30 minutes at 2500 rpm 
at room temperature. Cells with viruses were incubated 6 hours + 37 °C, and after that medium was changed. 
Transduction was carried out for three days followed by splitting the cells. Selection was done with 1 μg/ml 
puromycin (Sigma-Aldrich) for shRNA transduced cells and selection was carried out for at least six days. For 
transduction with overexpression construct selection was done using 2 μg/ml of Blasticidin S HCl (Invitrogen).
Immunofluoresence. Cells were seeded to glass coverslips and incubated overnight. After cells were 
attached, they were fixed with 4% paraformaldehyde in phosphate-buffered salin (PBS) for 15 minutes, and 
washed with PBS. Cells were permeabilized with 0,1% Triton-X for 5 minutes, and incubated with 0,12% glycin in 
PBS for 10 minutes. Cells were blocked with 3% bovine serum albumin (BSA) for 30 minutes and incubated with 
primary antibody for 1 hour or overnight in 3% BSA. Cells were washed with PBS and incubated in secondary 
antibody for 1 hour. Cells were washed with PBS and milli-Q water, and mounted in mounting medium Mowiol, 
1,4-diazobicyclo (2,2,2) octane (DABCO) and 4′ 6-diamidino-2-phenylindole (DAPI) to stain the nucleus.
Microscopy. Confocal images were collected using Zeiss Meta 780 laser scanning microscope with Zeiss 40x 
or 63x/1.4 N.A. plan-apochromat oil objective at room temperature. Acquisition was made with Zeiss Zen 2010 
Lite program. Images were adjusted with Adobe Photoshop CS6 and Illustrator CS6 software.
Western blot. Cells were seeded overnight, washed with PBS and lysed to lysis buffer RIPA (Sigma-Aldrich), 
with protease inhibitors (phosphatase inhibitor cocktail, Roche) and phosphatase inhibitors (complete protease 
inhibitor cocktail, Roche). Samples were rotated 10 minutes at + 4 °C and incubated on ice 30 minutes followed by 
centrifugation for 13,000 rpm 10 minutes + 4 °C. Protein concentrations were measured by RC DC Protein Assay 
Kit (BioRad). Samples were denatured by boiling them in + 95 °C for 5 minutes with added loading buffer (5% 
β -mercaptoethanol and 2 x Laemmli buffer, BioRad) in ratio 1:1. Ready-made SDS-gels (BioRad) were used, and 
5–10 μg protein was loaded into gel. Proteins were blotted from gels to polyvinylidene fluoride (PVDF) mem-
branes (BioRad) using TransferBlot Turbo (BioRad) equipment. Membranes were blocked with 5% milk in tris 
buffered saline and 0,05% Tween (TBST) for 1 hour, washed with TBST, and incubated with primary antibody 
for 1 hour to overnight, and washed with TBST. Membranes were incubated with secondary antibody 1 hour, 
and washed with TBST. Detection reagents were added to membranes (Millipore) and chemiluminescence was 
detected to X-ray films (Kodak).
Immunoprecipitation. Cells were counted and plated on cell culture dish and incubated + 37 °C overnight. 
Cells were washed with ice cold PBS and scraped off the dish using a plastic cell scraper. Cells were lysed to lysis 
buffer containing 20 mM Tris-HCl, 150 mM NaCl, 1 mM sodium orthovanadate, 10 mM NaF, 1 mM EDTA, 1% 
TX-100 and protease inhibitors. Cell lysates were then pre-cleared by incubating them with immobilized protein 
A bead (GE Healthcare) slurry for 30 minutes. Pre-cleared cell lysates were incubated in rotation with liprin-α 1 
antibody for endogenous protein and beads for 2 hours at + 4 °C. Tubes were centrifuged, supernatant removed 
and beads washed in lysis buffer. For immunoblotting, the final supernatant was removed and followed by adding 
the loading buffer (5% β -mercaptoethanol and 2 × Laemmli buffer, BioRad). Samples were boiled in + 95 °C for 
5 minutes to denature the protein and separate it from the beads, samples were centrifugated and supernatant 
collected, after which western blot was performed.
Colony growth formation assay. 0,7% bottom agar layer was prepared day before plating the cells onto 
6-well plate and incubated in + 37 °C overnight. Next day cells were calculated (5000 cells/ml) and mixed with 
medium and 0,35% top agar and plated on 6-well plates on top of bottom agar. Plates were incubated on + 37 °C 
for three weeks. Colonies were stained with 0,005% crystal violet/methanol, and incubated overnight + 4 °C. 
Colonies were washed with Milli-Q water several times. Colonies were imaged with Leica MZ FL III stereomicro-
scope. Camera was The Soft ImagingSystems View Fire Wire camera and software Soft ImagingSystems analySIS. 
Quantification and calculations were made with Adobe Photoshop CS6 software.
Cell growth assay. Cells were trypsinized and counted, and seeded onto 96-well plate. Cells were incubated 
for 2–6 days, and thiazolyl blue tetrazolium bromide (MTT, 0,5 mg/ml) reagent was added to cells to assess cell 
viability and growth. MTT was incubated with cells 2 hour after which cells were lysed to lysis buffer (10% SDS, 
10 nM HCl), and incubated + 37 °C overnight, after which absorbance was measured with Victor plate reader at 
wavelength at 540 nm.
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Gelatin degradation assay. Coverslips were coated with poly-L-lysine (50 μg/ml, Sigma-Aldrich), and 
washed with PBS. Coverslips were fixed with 0,5% glutaraldehyde (Sigma-Aldrich), and washed with PBS. 
Coverslips were coated with 1 mg/ml Oregon green gelatin mixed with 2 mg/ml denatured collagen I, and washed 
with PBS. Coverslips were incubated with 5 mg/ml sodium borohydride (Sigma-Aldrich), and washed with PBS. 
Coverslips were incubated in complete medium overnight. Cells were counted and seeded to coverslips. Cells 
were incubated in complete medium, and fixed with 4% PFA.
Quantification of focal adhesions and extracellular matrix degradation. Focal adhesions and 
extracellular matrix degradation were quantified by ImageJ software. After thresholding the background, vinculin 
positive focal adhesions were quantified by function analyzing particles. Average size or shape of focal adhesions 
were quantified by analyzing three times 30 cells from different experiments. Focal adhesions were defined by 
intensity threshold, and images were inverted to black and white. Area of focal adhesions were set from five to 
infinity and circularity was set from 0 to 1 of the total area. To quantify particles with elongated shape, circularity 
was set from 0 to 0,5. For quantification of extracellular matrix degradation, background was first defined by 
intensity threshold and degradation area was set from one to infinity and circularity from 0 to 1. For quanti-
fication of extracellular matrix > 50 cells/experiment were analyzed. Error bars were calculated from standard 
deviations of three experiments. Unpaired student’s t-test was used for statistical analysis and result was regarded 
significant if P < 0.05. Confocal images were collected using Zeiss Meta 780 laser scanning microscope with Zeiss 
40x/1.4 N.A. plan-apochromat oil objective at room temperature.
Microarray analysis. RNA from UT-SCC-95 and UT-SCC-24B cell lines was extracted using miRNeasy 
Mini kit from Qiagen according to manufacturer’s protocol. The RNA was analyzed for integrity and quality on 
Agilent Bioanalyzer 2100. Two different arrays were used. UT-SCC-95 was hybridized into Affymetrix Human 
Exon 1.0 arrays. Starting amount of total RNA was 100 ng and 15 μg of cRNA and 5,5 μg of sscDNA were used for 
labeling. The labeling and hybridization were done according to the manufacturer’s instructions. Protocols used 
for arrays were the Ambion WT Expression Kit for Affymetrix GeneChip Whole Transcript (WT) Expression 
Arrays (Part 4425209 Rev. C) and GeneChip WT Terminal Labeling and Hybridization User Manual for use 
with the Ambion WT Expression Kit (P/N 702808 Rev. 4). One-hundred nanograms of total RNA extracted 
from UT-SCC-24B cell line was hybridized into Affymetrix Human Gene 2.0 ST arrays, and 15 μg of cRNA and 
5,5 μg sscDNA were used for labeling. The labeling and hybridization were done according to the manufactur-
er’s instructions. Protocols and reagents for Human Gene 2.0 ST arrays were GeneChip® WT Plus Reagent Kit, 
Manual Target Preparation for GeneChip® Whole Transcript Expression Arrays (P/N 703174 Rev.2), Affymetrix 
GeneChip® Expression Wash, Stain and Scan User Manual For Cartridge Arrays (P/N 702731 Rev. 3, Affymetrix). 
The microarray data discussed in this publication have been deposited to NCBI’s Gene Expression Omnibus and 
are accessible through GEO Series accession number GSE75756 (http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?&acc= GSE75756).
3D type I collagen growth and invasion assays. Type I collagen (2,2 mg/ml) was prepared; invasion 
and growth were assessed essentially as described54. For invasive growth assay, single cell suspension with 3000 
cells was mixed in collagen and cultured for 5 (Fig. 1) or 9 (Fig. 4) days. Cultures were fixed and the cells were 
visualized by staining with phalloidin for filamentous actin and DAPI for nuclei.
For quantification of invasive growth, the area of invading and non-invading cell colonies were measured 
by outlining the colony boundary and calculating the area using Image J software. In addition, the number of 
nuclei were counted from each cell colony from random epifluorescence images of at least three gels. The invasive 
growth, expressed as the ratio of cell colony area/number of nuclei, represents the level of cell colony branching in 
3D collagen. Alternatively, the number of colonies displaying invasive growth as cellular sprouts was counted and 
invasive growth was expressed as the ratio of invasive colonies/total colonies (Fig. 4A,B). The numerical values 
represent mean + /− SEM in invasive growth assays. Statistical significance was determined using the unpaired 
Student’s t- test.
Transwell migration assay. Transwell cell migration assay was performed using 24-well plates (BD 
Biosciences) with cell culture inserts (8 μm pore size in the membrane, BD Biosciences). For analysis of cell 
migration, the upper surface of the membrane was coated with Matrigel without growth factors diluted in cold 
serum-free DMEM at the concentration 200 μg/ml and incubated at 37 °C for 1 h to allow the Matrigel to solidify. 
Cells were washed with PBS, resuspended in the medium with 10% FBS and incubated at 37 °C for 2 h. After 
incubation cells were washed three times with PBS and resuspended in serum-free medium supplemented with 
0.1% albumin solution (BSA, Sigma-Aldrich). Cell suspension (8 × 104 cells per ml, 250 μl) was added to the 
upper chamber, and complete medium (750 μl) with 10% FBS was added to the bottom wells of the chambers. The 
cells that had migrated to the lower surface of the membranes were fixed with methanol for 20 min, stained with 
Hoechst and quantified using Cellomics ArrayScan 4.5 (Thermo Scientific). The upper surface of the chambers 
were cleaned using cotton swabs. Images of 30 fields were captured from each membrane and the number of cells 
migrating through the insert was counted. The average of duplicate assays for each experimental condition was 
used, and experiment was repeated three times. The error bars were calculated from standard deviations from 
three different experiments.
Spheroid formation assay. Cells were counted and 10000 cells/well were plated to low adhesion plates 
(Corning), where cells where allowed to form spheroid structures for four days. Spheroids were imaged with 
phase contrast microscope Motic and software Motic. Images were processed with Adobe Photoshop CS6 and 
Adobe Illustrator CS6.
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Soluble and insoluble fractioning. Cells were incubated at + 4 °C for 30 minutes with phosphobuffer 
(NaCl 150 mM, Hepes 20 mM pH 7,6, 1% Igepal, 10% glycerol) containing phosphatase inhibitors (phosphatase 
inhibitor cocktail, Roche), and protease inhibitors (complete protease inhibitor cocktail, Roche) followed by 
scraping them off from cell culture flasks. Samples were centrifuged at 20,000 g at + 4 °C for 20 minutes. The 
supernatant (soluble fraction) was collected while the pellet (insoluble fraction) was washed three times with 
2 mM EDTA in PBS, resuspended in Triton buffer (PBS, 1% SDS, 0,1% Triton), and then boiled for 10 min, and 
pipetted through a needle several times55. Soluble and insoluble fraction were separated by SDS page, transferred 
to PVDF-membrane and probed with the antibodies, and detected by chemiluminescence.
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